Primary Site >> Pancreatic Cancer
Gene >> LATS2
| 1. | |||||||||||
| Journal: | Int J Oncol. 2012 Dec;41(6):1913-8. | ||||||||||
| Title: | Function and cancer genomics of FAT family genes (review). | ||||||||||
| Author: | Katoh, Masaru | ||||||||||
| PMID: | 23076869 | ||||||||||
| 2. | |||||||||||
| Journal: | EMBO Mol Med. 2013 Sep;5(9):1322-34. | ||||||||||
| Title: | A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. | ||||||||||
| Author: | Zhang, Yuqing|Yang, Jingxuan|Cui, Xiaobo|Chen, Yong|Zhu, Vivian F|Hagan, John P|Wang, Huamin|Yu, Xianjun|Hodges, Sally E|Fang, Jing|Chiao, Paul J|Logsdon, Craig D|Fisher, William E|Brunicardi, F Charles|Chen, Changyi|Yao, Qizhi|Fernandez-Zapico, Martin E| | ||||||||||
| PMID: | 23857777 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncotarget. 2015 Dec 29;6(42):44466-79. | ||||||||||
| Title: | Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. | ||||||||||
| Author: | Chen, Meiyuan|Wang, Min|Xu, Simiao|Guo, Xingjun|Jiang, Jianxin | ||||||||||
| PMID: | 26561204 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncotarget. 2017 Sep 11;8(45):78556-78572. | ||||||||||
| Title: | STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines. | ||||||||||
| Author: | Grant, Trevor J|Mehta, Anita K|Gupta, Anamika|Sharif, Ahmad A D|Arora, Kshitij S|Deshpande, Vikram|Ting, David T|Bardeesy, Nabeel|Ganem, Neil J|Hergovich, Alexander|Singh, Anurag | ||||||||||
| PMID: | 29108249 | ||||||||||
| 5. | |||||||||||
| Journal: | J Biol Chem. 2018 Jan 26;293(4):1178-1191. | ||||||||||
| Title: | Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. | ||||||||||
| Author: | Zhu, Chu|Ji, Xinyan|Zhang, Haitao|Zhou, Qi|Cao, Xiaolei|Tang, Mei|Si, Yuan|Yan, Huan|Li, Li|Liang, Tingbo|Feng, Xin-Hua|Zhao, Bin | ||||||||||
| PMID: | 29183995 | ||||||||||